These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26378384)

  • 1. Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy.
    Rai R; Ahuja CK; Agrawal S; Kalra N; Duseja A; Khandelwal N; Chawla Y; Dhiman RK
    Clin Transl Gastroenterol; 2015 Sep; 6(9):e111. PubMed ID: 26378384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Cerebral Edema in Acute-on-Chronic Liver Failure.
    Gupta T; Dhiman RK; Ahuja CK; Agrawal S; Chopra M; Kalra N; Duseja A; Taneja S; Khandelwal N; Chawla Y
    J Clin Exp Hepatol; 2017 Sep; 7(3):190-197. PubMed ID: 28970705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal.
    Pawar VB; Surude RG; Sonthalia N; Zanwar V; Jain S; Contractor Q; Rathi PM
    J Clin Transl Hepatol; 2019 Dec; 7(4):304-312. PubMed ID: 31915599
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.
    Srivastava A; Chaturvedi S; Gupta RK; Malik R; Mathias A; Jagannathan NR; Jain S; Pandey CM; Yachha SK; Rathore RKS
    J Hepatol; 2017 Mar; 66(3):528-536. PubMed ID: 27815224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
    Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
    Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant inter-hemispheric coordination characterizes the progression of minimal hepatic encephalopathy in patients with HBV-related cirrhosis.
    Ye M; Guo Z; Li Z; Lin X; Li J; Jiang G; Teng Y; Qiu Y; Han L; Lv X
    Neuroimage Clin; 2020; 25():102175. PubMed ID: 31954985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
    J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Regional Homogeneity and Functional Connectivity of Baseline Brain Activity in Hepatitis B Virus-Related Cirrhosis With and Without Minimal Hepatic Encephalopathy.
    Sun Q; Fan W; Ye J; Han P
    Front Hum Neurosci; 2018; 12():245. PubMed ID: 29988437
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
    Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
    Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.
    Moratalla A; Ampuero J; Bellot P; Gallego-Durán R; Zapater P; Roger M; Figueruela B; Martínez-Moreno B; González-Navajas JM; Such J; Romero-Gómez M; Francés R
    Liver Int; 2017 Feb; 37(2):212-223. PubMed ID: 27388776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity.
    Casanova-Ferrer F; Gallego JJ; Fiorillo A; Urios A; Ríos MP; León JL; Ballester MP; Escudero-García D; Kosenko E; Belloch V; Montoliu C
    J Transl Med; 2024 Jan; 22(1):49. PubMed ID: 38217008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.
    Rathi S; Chopra M; Chouduri G; Sharma P; Madan K; Chhabra M; Rai RR; Govil A; Konar A; Goenka M; Agarwal M; Mukherjee J; Thorat V; Salunkhe S; Abraham P; Nagral A; Jhaveri A; Bhat N; Varghese J; R S A; Ravishankar ; Reddy DC; Dhiman RK
    J Clin Exp Hepatol; 2019; 9(4):476-483. PubMed ID: 31516264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.